New study aims to improve monitoring of hepatitis d treatment
NCT ID NCT07313358
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This study looks at data and samples from 220 adults with hepatitis D who are already taking the drug bulevirtide. Researchers want to see how well the drug works over time and find markers that can predict treatment success. The goal is to improve how doctors monitor patients and make treatment more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HDV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heinrich Heine University
Düsseldorf, Germany, 40225, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Università di Milano
Milan, Italy, 20122, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.